MAPT and Alzheimer disease: Silencing Cdk5 via RNA interference (RNAi) using lentiviral or adenoassociated viral vectors in the brains of transgenic AD mouse models show reduction in phosphorylation of tau and decreased number of NFTs in the hippocampus [145].